| Product Code: ETC8284881 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Onchocerciasis Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Onchocerciasis Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Onchocerciasis Market - Industry Life Cycle |
3.4 Mexico Onchocerciasis Market - Porter's Five Forces |
3.5 Mexico Onchocerciasis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 Mexico Onchocerciasis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Mexico Onchocerciasis Market Revenues & Volume Share, By Drug, 2021 & 2031F |
3.8 Mexico Onchocerciasis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Mexico Onchocerciasis Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 Mexico Onchocerciasis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mexico Onchocerciasis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about onchocerciasis and its impact on public health in Mexico |
4.2.2 Government initiatives and funding for onchocerciasis control and prevention programs |
4.2.3 Technological advancements in diagnosis and treatment of onchocerciasis |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in rural areas where onchocerciasis is prevalent |
4.3.2 Lack of trained healthcare professionals for onchocerciasis management in Mexico |
4.3.3 High cost of medications and treatments for onchocerciasis patients |
5 Mexico Onchocerciasis Market Trends |
6 Mexico Onchocerciasis Market, By Types |
6.1 Mexico Onchocerciasis Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 Mexico Onchocerciasis Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 Mexico Onchocerciasis Market Revenues & Volume, By Physical Examination, 2021- 2031F |
6.1.4 Mexico Onchocerciasis Market Revenues & Volume, By Skin Biopsy, 2021- 2031F |
6.1.5 Mexico Onchocerciasis Market Revenues & Volume, By Mazzotti Test, 2021- 2031F |
6.1.6 Mexico Onchocerciasis Market Revenues & Volume, By Nodulectomy, 2021- 2031F |
6.1.7 Mexico Onchocerciasis Market Revenues & Volume, By PCR Test, 2021- 2031F |
6.1.8 Mexico Onchocerciasis Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Mexico Onchocerciasis Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Mexico Onchocerciasis Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 Mexico Onchocerciasis Market Revenues & Volume, By Supportive Care, 2021- 2031F |
6.2.4 Mexico Onchocerciasis Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Mexico Onchocerciasis Market, By Drug |
6.3.1 Overview and Analysis |
6.3.2 Mexico Onchocerciasis Market Revenues & Volume, By Ivermectin, 2021- 2031F |
6.3.3 Mexico Onchocerciasis Market Revenues & Volume, By Moxidectin, 2021- 2031F |
6.3.4 Mexico Onchocerciasis Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Mexico Onchocerciasis Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Mexico Onchocerciasis Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Mexico Onchocerciasis Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Mexico Onchocerciasis Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Mexico Onchocerciasis Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Mexico Onchocerciasis Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Mexico Onchocerciasis Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 Mexico Onchocerciasis Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Mexico Onchocerciasis Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Mexico Onchocerciasis Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Mexico Onchocerciasis Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.4 Mexico Onchocerciasis Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Mexico Onchocerciasis Market Import-Export Trade Statistics |
7.1 Mexico Onchocerciasis Market Export to Major Countries |
7.2 Mexico Onchocerciasis Market Imports from Major Countries |
8 Mexico Onchocerciasis Market Key Performance Indicators |
8.1 Number of people screened for onchocerciasis annually |
8.2 Percentage of onchocerciasis cases diagnosed at an early stage |
8.3 Adoption rate of new technologies for onchocerciasis diagnosis and treatment |
8.4 Level of government funding allocated to onchocerciasis control programs |
8.5 Percentage of onchocerciasis patients completing prescribed treatment regimens |
9 Mexico Onchocerciasis Market - Opportunity Assessment |
9.1 Mexico Onchocerciasis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 Mexico Onchocerciasis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Mexico Onchocerciasis Market Opportunity Assessment, By Drug, 2021 & 2031F |
9.4 Mexico Onchocerciasis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Mexico Onchocerciasis Market Opportunity Assessment, By End User, 2021 & 2031F |
9.6 Mexico Onchocerciasis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mexico Onchocerciasis Market - Competitive Landscape |
10.1 Mexico Onchocerciasis Market Revenue Share, By Companies, 2024 |
10.2 Mexico Onchocerciasis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here